SEARCH HEALTH CONDITIONS BY ALPHABETS
Postural Orthostatic Tachycardia Syndrome
Medications for Postural Orthostatic Tachycardia Syndrome
Other titles: Chronic Orthostatic Intolerance; Postural Tachycardia Syndrome; POTS
About Postural Orthostatic Tachycardia Syndrome: Postural orthostatic tachycardia syndrome (POTS) is a disorder in that an excessively low level of blood flow into the center after a person stands up from a lying position. The main symptom is fainting or light headedness.
Drugs Used to Cure Postural Orthostatic Tachycardia Syndrome
This list of medications are found in the treatment of this illness, or in some way associated with.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| midodrineOff Label | Rx | C | N | 10 testimonials | 6.9 | ||
Generic title: midodrine systemic Brand title: Orvaten Drug class: miscellaneous Cardio Vascular agents For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
| fludrocortisoneOff Label | Rx | C | N | 1-5 testimonials | 8.2 | ||
Generic title: fludrocortisone systemic Brand titles: Florinef, Florinef Acetate Medication course: mineralocorticoids For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
| FlorinefOff Label | Rx | C | N | 5 testimonials | 8.7 | ||
Generic title: fludrocortisone systemic Medication course: mineralocorticoids For customers: dose, interactions, and side effects For specialists: Prescribing Information Off Label: Yes | |||||||
| sodium chloride | Rx/OTC | C | N | Insert review | 10 | ||
Generic title: sodium chloride systemic Medicine class: vitamins and electrolytes, mixed respiratory agents For customers: interactions, For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| clonidineOff Label | Rx | C | N | X | 3 testimonials | 6.7 | |
Generic title: clonidine systemic Medication course: antiadrenergic agents, centrally acting For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
| methylphenidateOff Label | Rx | C | Two | X | Inch review | 8.0 | |
Generic title: methylphenidate systemic Drug course: CNS stimulants For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
| OrvatenOff Label | Rx | C | N | Inch review | 9.0 | ||
Generic title: midodrine systemic Drug class: miscellaneous Cardio Vascular agents For customers: dose, interactions, and side effects For specialists: AHFS DI Monograph Off Label: Yes | |||||||
| bupropionOff Label | Rx | C | N | X | 3 testimonials | 8.5 | |
Generic title: bupropion systemic Drug course: mixed antidepressants, smoking cessation agents For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
| Florinef AcetateOff Label | Rx | C | N | 3 testimonials | 8.8 | ||
Generic title: fludrocortisone systemic Medication course: mineralocorticoids For customers: dose, interactions, and side effects For specialists: AHFS DI Monograph Off Label: Yes | |||||||
| labetalolOff Label | Rx | C | N | X | Insert review | 0.0 | |
Generic title: labetalol systemic Medication course: non-cardioselective beta blockers For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
| octreotideOff Label | Rx | B | N | Insert review | 0.0 | ||
Generic title: octreotide systemic Medication course: somatostatin and somatostatin analogs For customers: dose, interactions, For specialists: Az Drug Truth, AHFS DI Monograph, Prescribing Information Off Label: Yes | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Away Tag | This drug might well not be approved by the FDA for the treatment of this illness. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have shown a negative effect in the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women clearly outweigh potential rewards. |
| N | FDA have not classified this drug. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | features a high possibility of abuse. Has no currently accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| 2 | features a high possibility of abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe emotional or physical dependency. |
| 3 | Has a possibility for abuse less than people in programs 1 and 2 two. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | features a very low potential for abuse in accordance with people in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to people in schedule 3. |
| 5 | features a very low potential for abuse in accordance with people in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Runciman
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask with your physician to be sure the information applies to your personal circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
